KRED

Monday, May 15, 2017

Time to Focus on LeMaitre Vascular (LMAT) for Strong Earnings Growth Potential

http://ift.tt/2qjomtf

Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, these can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses.

One such company that might be well-positioned for future earnings growth is LeMaitre Vascular LMAT. This firm, which is in the Medical – Products industry, saw EPS growth of 31% last year, and is looking great for this year too.

In fact, the current growth estimate for this year calls for earnings-per-share growth of 27.3%. Furthermore, the long-term growth rate is currently an impressive 15%, suggesting pretty good prospects for the long haul.

LeMaitre Vascular, Inc. Price and Consensus

LeMaitre Vascular, Inc. Price and Consensus | LeMaitre Vascular, Inc. Quote

And if this wasn’t enough, the stock has actually seen estimates rise over the past month for the current fiscal year by about 4.5%. Thanks to this rise in earnings estimates, LMAT has a Zacks Rank #2 (Buy) which further underscores the potential for outperformance in this company. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So if you are looking for a fast growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider LMAT. Not only does it have double digit earnings growth prospect, but its impressive Zacks Rank suggests that analysts believe better days are ahead for LMAT as well.

5 Trades Could Profit “Big-League” from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington’s changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
LeMaitre Vascular, Inc. (LMAT): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

May 15, 2017 at 06:36PM

http://ift.tt/2rhFc9l

from Zacks Equity Research

http://ift.tt/2rhFc9l